FierceBiotech ٣٠ يناير ٢٠٢٦ Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
FierceBiotech ٢٩ يناير ٢٠٢٦ Formation Bio’s China shopping spree continues with $500M biobucks autoimmune pact
FierceBiotech ٢٩ يناير ٢٠٢٦ Roche diagnostics business nudges up 2% in '25 as China headwinds buffet Asia-Pacific sales
FierceBiotech ٢٩ يناير ٢٠٢٦ Belgium biotech Agomab outlines up to $212M Nasdaq debut to fund immunology trials
FierceBiotech ٢٩ يناير ٢٠٢٦ Sanofi keeps mum on future of disappointing Denali pact after scrapping final RIPK1 inhibitor
FierceBiotech ٢٩ يناير ٢٠٢٦ AstraZeneca vows $15B China investment to boost cell therapy and radioconjugate capabilities
FierceBiotech ٢٩ يناير ٢٠٢٦ Repertoire adds Lilly to range of Big Pharma partners in autoimmune deal worth up to $2.69B
FierceBiotech ٢٨ يناير ٢٠٢٦ Reducing animal testing 'an evolution and not a revolution' for life sci R&D, Charles River's incoming CEO says
FierceBiotech ٢٨ يناير ٢٠٢٦ New compound shrinks brain tumors in mice, sparking hope for a glioblastoma pill
FierceBiotech ٢٨ يناير ٢٠٢٦ Halozyme catches M&A wave to snap up Surf Bio in delivery tech deal worth up to $400M
FierceBiotech ٢٨ يناير ٢٠٢٦ Lilly pens $1.1B pact with German biotech to work on gene editing med for hearing loss
FierceBiotech ٢٨ يناير ٢٠٢٦ Medtech M&A 'rebounded' in 2025 as softer valuations drove deal competition: report
FierceBiotech ٢٨ يناير ٢٠٢٦ CalciMedica stock craters as calcium channel inhibitor trial stopped over 'safety concern'